News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Akhil Santhosh: Primary efficacy and safety results from the AMALEE trial
Breast Cancer
Jan 15, 2025, 14:04

Akhil Santhosh: Primary efficacy and safety results from the AMALEE trial

Akhil Santhosh, Medical Oncologist at AIIMS Delhi, shared an article by Fatima Cardoso on X:

“Primary efficacy and safety results from the AMALEE trial evaluating 600 vs 400 mg starting doses of first-line ribociclib in patients with advanced BC.

400mg ribo has a better side effect profile but failed to meet non inferiority vs 600mg.”

Abstract PD17-12: Primary efficacy and safety results from the AMALEE trial evaluating 600 mg vs 400 mg starting doses of first-line ribociclib in patients with HR+/HER2− advanced breast cancer.

Authors: Fatima Cardoso, et al.

Akhil Santhosh: Primary efficacy and safety results from the AMALEE trial

More posts featuring Akhil Santhosh.

Abstract PD17-12 AIIMS DELHI Akhil Santhosh AMALEE trial Breast Cancer cancer Fatima Cardoso fight against cancer Global fight against cancer OncoDaily Oncology Ribociclib
Special Coverage
Voices
Sep 3, 2025, 06:15
Sumanta Pal: Congratulations to Cristiane D Bergerot on ASCO Global Guideline on Geriatric Assessment
Societies
Sep 3, 2025, 05:47
Join ESMO AI and Digital Oncology Congress 2025 - ESMO
Voices
Sep 2, 2025, 22:37
Tyler Seibert: How Much Can A GG2 Prostate Cancer Grow in 2 Months?
Societies
Sep 2, 2025, 22:03
European Liver Screening Week - European Liver Patients'​ Association
Science
Sep 2, 2025, 21:19
Mohamed Emam Sobeih: The Efficacy of Benson’s Relaxation Technique on Anorexia and Sleep in Cancer Patients
Voices
Sep 2, 2025, 20:50
Anton Gokin: Latest Updates in Oncology Market and Science
Science
Sep 2, 2025, 20:26
Yinghui Li: Novel lncRNA PLUM Drives Chemoresistance in Multiple Myeloma Through PRC2 Pathway
Societies
Sep 2, 2025, 18:53
A Busy Month of Global Healthcare Innovation and Conferences - EHFF
Voices
Sep 2, 2025, 18:26
Tong Yin Shared Details of AstraZeneca’s ECP Symposium on Breast Cancer Diagnostics
Voices
Sep 2, 2025, 17:36
Tackling Hepatitis and Its Connection to Liver Cancer - European Cancer Organisation
Blog Posts
Sep 2, 2025, 17:24
Launching the 10th LuCE Report: Marking a Decade of Evidence from Lived Experience
Career Updates
Sep 2, 2025, 17:15
Joaquim Bosch-Barrera Begins New Role as Associate Adjunct Professor at ICO